Fig. 1: Characterisation of molecular subtypes in the MYCN non-amplified neuroblastomas. | British Journal of Cancer

Fig. 1: Characterisation of molecular subtypes in the MYCN non-amplified neuroblastomas.

From: Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification

Fig. 1

a Workflow showing the study design (details provided in the Supplementary Methods). b Consensus clustering of top 50% variable genes of train cohort. c Principal component analysis (PCA) showing neuroblastoma patients with subgroup annotations.

Back to article page